Texas Health Atlas · Houston
Moleculin Biotech
Developing treatments for hard-to-treat tumors and viruses.
- Location
- Houston, Texas
- Focus
- Biotechnology
- Stage / status
- Late-stage clinical (per company)
- Notes
- Lead program: Annamycin, in the MIRACLE pivotal Phase 3 trial for second-line acute myeloid leukemia (AML).
- Website
- moleculin.com
- Last reviewed
- Sep 29, 2026
Sources
Regulatory status is as stated by the company or its public filings on the review date; it changes. Work here? Send a correction or update.